Journal of Antimicrobial Chemotherapy (2002) 49, 11-19
© 2002 The British Society for Antimicrobial Chemotherapy
Supplement |
Diagnosis of fungal infections: current status
Division of Infectious Diseases, Department of Medicine, Santa Clara Valley Medical Center, Stanford University Medical School, San Jose, CA, USA
Abstract
Diagnosing infections remains a problem in the management of fungal diseases, particularly in the immunocompromised host. Signs and symptoms are non-specific, colonization is difficult to distinguish from invasive disease, blood cultures are commonly negative and patients are often unable to undergo invasive diagnostic procedures. This situation has led to the strategy of initiating empirical therapy in the high-risk patient. A variety of tests has been applied to several body fluids. At the simplest level, the clinician must be familiar with the appearance of various fungi in tissue. Non-culture methods include antibody- and antigen-based assays, metabolite detection and molecular identification. The latter includes PCR identification of fungal DNA from body fluid samples using conserved or specific genome sequences. Detection of glucan in blood has been achieved using crab amoebocyte lysate. With aspergillosis, predictive clinical correlates have been defined, respiratory tract cultures are highly predictive of invasive disease in the appropriate setting and certain CT scan findings enable early diagnosis. Bronchoalveolar lavage is also very useful. Galactomannan antigen testing of blood is routine in some European centres, with EIA methodology supplanting agglutination because of apparently greater sensitivity. PCR has been made specific by genus-specific probes, with 100% sensitivity and reasonable specificity. In candidosis, the number of sites of colonization correlates with invasion. Tests for mannan antibodies and antigenaemia are currently of interest. Metabolite assays appeared promising but have not been pursued commercially. In cryptococcosis, pronase treatment of serum has reduced false positives and false negatives, and improved reproducibility of titres. Birdseed agar improves culture specificity. In coccidioidomycosis, serology is the exemplar for all mycology. Gene probes have accelerated diagnosis by culture. In histoplasmosis, the antigenuria test's high sensitivity and specificity has dispelled the chronic confusion in interpreting antibody test results.
Notes
* Correspondence address. Division of Infectious Diseases, Department of Medicine, Santa Clara Valley Medical Center, 751 South Bascom Avenue, San Jose, CA 95128-2699, USA. Tel: 1-408-855-4303; Fax: 1-408-855-4306; E-mail: stevens{at}leland.stanford.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Poole Efflux-mediated antimicrobial resistance J. Antimicrob. Chemother., July 1, 2005; 56(1): 20 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Hinrikson, S. F. Hurst, T. J. Lott, D. W. Warnock, and C. J. Morrison Assessment of Ribosomal Large-Subunit D1-D2, Internal Transcribed Spacer 1, and Internal Transcribed Spacer 2 Regions as Targets for Molecular Identification of Medically Important Aspergillus Species J. Clin. Microbiol., May 1, 2005; 43(5): 2092 - 2103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Edlind, W. L. Smith, and T. D. Edlind Effects of Cetylpyridinium Chloride Resistance and Treatment on Fluconazole Activity versus Candida albicans Antimicrob. Agents Chemother., February 1, 2005; 49(2): 843 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Sendid, T. Jouault, R. Coudriau, D. Camus, F. Odds, M. Tabouret, and D. Poulain Increased Sensitivity of Mannanemia Detection Tests by Joint Detection of {alpha}- and {beta}-Linked Oligomannosides during Experimental and Human Systemic Candidiasis J. Clin. Microbiol., January 1, 2004; 42(1): 164 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. McBain, R. G. Bartolo, C. E. Catrenich, D. Charbonneau, R. G. Ledder, and P. Gilbert Effects of Triclosan-Containing Rinse on the Dynamics and Antimicrobial Susceptibility of In Vitro Plaque Ecosystems Antimicrob. Agents Chemother., November 1, 2003; 47(11): 3531 - 3538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Sendid, D. Caillot, B. Baccouch-Humbert, L. Klingspor, M. Grandjean, A. Bonnin, and D. Poulain Contribution of the Platelia Candida-Specific Antibody and Antigen Tests to Early Diagnosis of Systemic Candida tropicalis Infection in Neutropenic Adults J. Clin. Microbiol., October 1, 2003; 41(10): 4551 - 4558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Digby, J. Kalbfleisch, A. Glenn, A. Larsen, W. Browder, and D. Williams Serum Glucan Levels Are Not Specific for Presence of Fungal Infections in Intensive Care Unit Patients Clin. Vaccine Immunol., September 1, 2003; 10(5): 882 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. McBain, R. G. Bartolo, C. E. Catrenich, D. Charbonneau, R. G. Ledder, and P. Gilbert Effects of a Chlorhexidine Gluconate-Containing Mouthwash on the Vitality and Antimicrobial Susceptibility of In Vitro Oral Bacterial Ecosystems Appl. Envir. Microbiol., August 1, 2003; 69(8): 4770 - 4776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Lewis, C. Torkornoo, C. N. H. Marques, S. M. Nelson, and V. C. Salisbury Inhibition of bacteria on agar surfaces by vapour phase triclosan J. Antimicrob. Chemother., August 1, 2003; 52(2): 314 - 315. [Full Text] [PDF]
|
|